Skip to main content
Erschienen in: Supportive Care in Cancer 7/2009

01.07.2009 | Original Article

Oral mucositis: a phenomenological study of pediatric patients’ and their parents’ perspectives and experiences

verfasst von: Karis Kin-fong Cheng

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Goal

The purpose of this qualitative phenomenological study was to describe children’s and their parents’ lived experiences of oral mucositis (OM) and to explore their needs in relation to OM.

Materials and methods

Individual semistructured interviews were conducted with 22 children who had experienced WHO grade ≥ 2 OM during chemotherapy within the previous 6 months. Parents from each family were also interviewed in the same way. Interviews were audio recorded and fully transcribed verbatim. Data were analyzed using inductive content analysis.

Results

The mean ages of the children and parents were 12 and 41 years, respectively. Regarding gender, 55% of the children were boys, and 95% of the parents were mothers or grandmother. Forty-one percent of the children were diagnosed with acute lymphoblastic leukemia, and 36% were treated with methotrexate. The findings illustrated that the experience of OM impacted on the lives of the children and their parents. Five themes, which subsumed a number of categories, were constructed: “Symptoms experienced,” “Negative emotional outcomes,” “The dilemma of eating (or not eating),” “Challenges in oral care,” “Health care needs.” Mouth and throat pain were found to cause a number of severe consequences in daily life. Many children experienced turmoil characterized by a panoply of emotions. All parents described psychological distress on various levels which they attributed to the burden of care and the suffering of their children. OM can present a difficult dilemma to patients: on the one hand, children found it too painful to chew and swallow food, while on the other hand they felt very hungry. Children were aware of the significance of oral care. Discomfort associated with oral care forced some children to neglect oral care. Parents also described oral care as a stressful event for their children and for them. Children needed more activities coordinated by the ward to distract them from their OM, as well as psychological support from the health care professionals. Parents indicated the need for more information about the process of OM and food selection.

Conclusion

Findings from this study illustrate the complex biopsychosocial impact of chemotherapy-induced OM on children and their parents. Optimal OM pain management guidelines and holistic supportive care strategies should be developed in conjunction with OM strategies in the future.
Literatur
1.
Zurück zum Zitat Barner C, Powell R, Ellis A et al (2007) Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer 15:427–440. doi:10.1007/s00520-006-0171-1 CrossRef Barner C, Powell R, Ellis A et al (2007) Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer 15:427–440. doi:10.​1007/​s00520-006-0171-1 CrossRef
2.
Zurück zum Zitat Bellm LA, Epstein JB, Rose-Ped P et al (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39PubMed Bellm LA, Epstein JB, Rose-Ped P et al (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39PubMed
4.
Zurück zum Zitat Boyatzis RE (1998) Transforming qualitative information: thematic analysis and code development. Sage, Thousand Oaks Boyatzis RE (1998) Transforming qualitative information: thematic analysis and code development. Sage, Thousand Oaks
7.
Zurück zum Zitat Cheng KKF, Chang AM, Yuen MP (2004) Prevention of chemotherapy-induced oral mucositis in pediatric patients: a randomized crossover trial comparing two protocols of oral care. Eur J Cancer 20:1208–1216. doi:10.1016/j.ejca.2003.10.023 CrossRef Cheng KKF, Chang AM, Yuen MP (2004) Prevention of chemotherapy-induced oral mucositis in pediatric patients: a randomized crossover trial comparing two protocols of oral care. Eur J Cancer 20:1208–1216. doi:10.​1016/​j.​ejca.​2003.​10.​023 CrossRef
10.
Zurück zum Zitat Cruz LB, Ribeiro AS, Rech A et al (2006) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer. doi:10.1002/pbc PubMed Cruz LB, Ribeiro AS, Rech A et al (2006) Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer. doi:10.​1002/​pbc PubMed
11.
Zurück zum Zitat De Koning BAE, Philipsen-Geerling B, Hoijer M et al (2007) Protection against chemotherapy induced mucositis by TGF-β2 in childhood cancer patients: results from a randomized cross-over study. Pediatr Blood Cancer 48:532–539. doi:10.1002/pbc.20910 PubMedCrossRef De Koning BAE, Philipsen-Geerling B, Hoijer M et al (2007) Protection against chemotherapy induced mucositis by TGF-β2 in childhood cancer patients: results from a randomized cross-over study. Pediatr Blood Cancer 48:532–539. doi:10.​1002/​pbc.​20910 PubMedCrossRef
13.
Zurück zum Zitat Dodd MJ, Dibble S, Miaskowski C et al (2001) A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21(6):498–505. doi:10.1016/S0885-3924(01)00277-9 PubMedCrossRef Dodd MJ, Dibble S, Miaskowski C et al (2001) A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21(6):498–505. doi:10.​1016/​S0885-3924(01)00277-9 PubMedCrossRef
15.
Zurück zum Zitat Fall-Dickson JM, Ramsay ES, Castro K et al (2007) Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Ther 29:2547–2561. doi:10.1016/j.clinthera.2007.12.004 PubMedCrossRef Fall-Dickson JM, Ramsay ES, Castro K et al (2007) Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Ther 29:2547–2561. doi:10.​1016/​j.​clinthera.​2007.​12.​004 PubMedCrossRef
17.
Zurück zum Zitat Isitt J, Murphy BA, Beaumont JL et al (2007) Oral mucositis-related morbidity and resource utilization in a prospective study of head and neck cancer patients. J Support Oncol 5:54–55 Isitt J, Murphy BA, Beaumont JL et al (2007) Oral mucositis-related morbidity and resource utilization in a prospective study of head and neck cancer patients. J Support Oncol 5:54–55
20.
Zurück zum Zitat Kwan, EPH, Cheng KKF (2008) Oropharyngeal mucositis, quality of life, and psychological distress of Hong Kong Chinese patients with head and neck cancer. The 4th Pan Pac Nurs Conf and the 6th Hong Kong Nurs Sym Cancer Care Kwan, EPH, Cheng KKF (2008) Oropharyngeal mucositis, quality of life, and psychological distress of Hong Kong Chinese patients with head and neck cancer. The 4th Pan Pac Nurs Conf and the 6th Hong Kong Nurs Sym Cancer Care
23.
Zurück zum Zitat Pan CX, Morrison S, Ness J et al (2000) Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life: a systematic review. J Pain Symptom Manage 20(5):374–387. doi:10.1016/S0885-3924(00)00190-1 PubMedCrossRef Pan CX, Morrison S, Ness J et al (2000) Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life: a systematic review. J Pain Symptom Manage 20(5):374–387. doi:10.​1016/​S0885-3924(00)00190-1 PubMedCrossRef
26.
Zurück zum Zitat Shaiova I, Lapin J, Manco L et al (2004) Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer 12:268–273. doi:10.1007/s00520-004-0595-4 PubMedCrossRef Shaiova I, Lapin J, Manco L et al (2004) Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer 12:268–273. doi:10.​1007/​s00520-004-0595-4 PubMedCrossRef
30.
Zurück zum Zitat Trotte A, Bellm LA, Epstein JB et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262. doi:10.1016/S0167-8140(02)00404-8 CrossRef Trotte A, Bellm LA, Epstein JB et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262. doi:10.​1016/​S0167-8140(02)00404-8 CrossRef
31.
Zurück zum Zitat Van Manen M (1990) Researching lived experience. Althouse, London, Ontario Van Manen M (1990) Researching lived experience. Althouse, London, Ontario
32.
Zurück zum Zitat World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva: Offset publication 48:15–22 World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva: Offset publication 48:15–22
33.
Zurück zum Zitat Zerbre MB, Parkerson SG, Ortielb ML et al (1992) Relationships between oral mucositis and treatment variable in bone marrow transplant patients. Cancer Nurs 15:196–205 Zerbre MB, Parkerson SG, Ortielb ML et al (1992) Relationships between oral mucositis and treatment variable in bone marrow transplant patients. Cancer Nurs 15:196–205
Metadaten
Titel
Oral mucositis: a phenomenological study of pediatric patients’ and their parents’ perspectives and experiences
verfasst von
Karis Kin-fong Cheng
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0618-2

Weitere Artikel der Ausgabe 7/2009

Supportive Care in Cancer 7/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.